USPTO Examiner BYRD BRIGID K - Art Unit 3771

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
19047456INTRAVASCULAR LITHOTRIPSY CATHETERFebruary 2025July 2025Allow510YesNo
18920744IMPLANT APPLICATORSOctober 2024February 2026Allow1600NoNo
18761645Variable Frequency Waveform Tattoo Needle MechanismJuly 2024February 2025Allow810YesNo
18747840Ultrasonic Surgical Irrigation Sleeve And Related AssembliesJune 2024November 2025Allow1720YesNo
18671511IMPLANT DELIVERY AND RETRIEVAL SYSTEMS AND METHODSMay 2024November 2025Allow1720YesNo
18656995Corneal Cutter and Method of UseMay 2024October 2024Allow610YesNo
18604732REPAIR PROSTHETIC CURL MITIGATIONMarch 2024January 2025Allow1010NoNo
18597895TROCARMarch 2024December 2024Allow900NoNo
18594395BALLOON GUIDE CATHETER WITH POSITIVE VENTING OF RESIDUAL AIRMarch 2024October 2025Abandon2020NoNo
18444535PACKAGING-INTEGRATED MANUALLY ACTUATED INTRAOCULAR LENS CARTRIDGEFebruary 2024September 2025Allow1920YesNo
18434360TACTICAL HEMOSTATIC BANDAGEFebruary 2024February 2026Allow2510NoNo
18422448CORNEAL LINEAR AXIS MARKERJanuary 2024December 2024Allow1110NoNo
18410419TATTOO APPLICATORJanuary 2024March 2026Abandon2610NoNo
18391049Device, system, and method for self dry needle for muscular pain or discomfortDecember 2023January 2026Abandon2510NoNo
18541489REMOVABLE VOLUME INDICATOR FOR SYRINGEDecember 2023March 2026Allow2720NoNo
18540439INJECTOR HAVING A FIRST PISTON AND A SECOND PISTONDecember 2023June 2024Allow610NoNo
18527742THROMBOSIS REMOVAL DEVICEDecember 2023February 2026Abandon2601NoNo
18524660SHOCK WAVE CATHETER WITH SHOCK ABSORBERNovember 2023December 2025Allow2521YesNo
18520222STENTED PROSTHESIS DELIVERY DEVICE HAVING TORQUE SHAFTNovember 2023April 2025Allow1620NoNo
18513421INTRAVASCULAR LITHOTRIPSY CATHETER WITH OSCILLATING IMPACTORNovember 2023June 2025Allow1820YesNo
18501431TISSUE RESECTING INSTRUMENT INCLUDING A ROTATION LOCK FEATURENovember 2023December 2024Allow1410NoNo
18486154MULTIFUNCTION OPHTHALMIC BLADEOctober 2023January 2026Allow2810NoNo
18482606DOUBLE-HEADED SURGICAL INSTRUMENTOctober 2023February 2025Abandon1650NoNo
18479869SYSTEMS AND METHODS FOR IMPLANTING LONGITUDINAL INTRAFASCICULAR ELECTRODESOctober 2023March 2024Allow610YesNo
18552940PUNCTURE DEVICESeptember 2023December 2025Abandon2710NoNo
18367897Device, system, and method for self dry needle for muscular pain or discomfortSeptember 2023December 2025Abandon2710NoNo
18464408TATTOO NEEDLE CARTRIDGESeptember 2023December 2025Abandon2710NoNo
18359833DEVICE AND METHOD FOR TREATING VASCULAR INSUFFICIENCYJuly 2023March 2026Allow3241YesYes
18271343DISPOSABLE BLOOD COLLECTING DEVICEJuly 2023January 2026Abandon3001NoNo
18347548HAIR REMOVAL DEVICEJuly 2023March 2024Allow810YesNo
18216084CATHETER SYSTEM WITH INDEPENDENTLY CONTROLLABLE BUBBLE AND ARC GENERATIONJune 2023September 2024Allow1410YesNo
18332615COAXIAL GUIDE NEEDLE FOR PUNCTURE TO PREVENT GAS EMBOLISMJune 2023December 2025Abandon3010NoNo
18256348SUPPORT DEVICE TO GUIDE TREATMENT INSTRUMENTS IN CLINICAL PROCEDURESJune 2023December 2025Abandon3110NoNo
18315143NEEDLE ASSEMBLY FOR TATTOO DEVICEMay 2023July 2025Allow2710NoNo
18144208INTRAVASCULAR LITHOTRIPSY CATHETERMay 2023October 2025Abandon2910NoNo
18142650INSTRUMENT SEAL FOR SURGICAL ACCESS ASSEMBLYMay 2023July 2024Allow1410YesNo
18140895RETRACTABLE PROTECTION AND/OR SENSING FEATURES FOR POWERED SURGICAL CUTTING DEVICES AND SYSTEMSApril 2023November 2025Allow3110YesNo
18308062VALVE PROSTHESIS HAVING A RADIALLY EXPANDABLE SLEEVE INTEGRATED THEREON FOR DELIVERY AND PREVENTION OF PARAVALVULAR LEAKAGEApril 2023November 2024Allow1901YesNo
18186240REPAIR PROSTHETIC CURL MITIGATIONMarch 2023December 2023Allow910NoNo
18178962Hand-held device for locally piercing a skinMarch 2023August 2025Abandon2910NoNo
18117118Oral Expansion DeviceMarch 2023January 2026Allow3530YesNo
18115262OPHTHALMO-SURGICAL INJECTORFebruary 2023September 2024Allow1920YesNo
18109187RADIALLY EXPANDABLE CANNULA SYSTEMS AND METHODS FOR USEFebruary 2023August 2025Allow3010YesNo
18018432INTRODUCTION DEVICE FOR THE PERCUTANEOUS INTRODUCTION OF DRAINAGE TUBES, IN PARTICULAR THORACIC DRAINAGE TUBESJanuary 2023January 2026Abandon3510NoNo
18159081Balloon Catheter With Venting of Residual Air in a Proximal DirectionJanuary 2023March 2025Allow2520YesNo
18158188SURGICAL CANNULA WITH REMOVABLE PRESSURE SEALJanuary 2023March 2024Allow1411NoNo
18150077BALLOON FOR CERVICAL RIPENINGJanuary 2023September 2024Allow2140YesNo
18066280ARTIFICIAL CHORDAE DEPLOYMENTDecember 2022January 2025Allow2510YesNo
17994810REUSABLE SURGICAL PORT WITH DISPOSABLE SEAL ASSEMBLYNovember 2022February 2025Allow2620NoNo
17999707MEDICAL ARM DEVICENovember 2022October 2025Allow3510YesNo
17956160DETERMINING PENETRATION PLANE OF A SURGICAL DEVICESeptember 2022October 2025Abandon3710NoNo
17909017Scalp clip gunSeptember 2022July 2025Allow3410YesNo
17822254EYE SURGERY METHOD USING SURGICAL CANNULATED INSTRUMENTAugust 2022December 2023Abandon1510NoNo
17822391METHOD AND APPARATUS FOR LOADING AND/OR UNLOADING SUTURE AND/OR A SHUTTLEAugust 2022September 2025Abandon3710NoNo
17894059FLY BY WIRE CONTROL FOR ATHERECTOMYAugust 2022December 2025Allow3920NoNo
17904763ORALLY ADMINISTRABLE INTRAGASTRIC BALLOONAugust 2022May 2025Abandon3310NoNo
17879762Tattoo Needle Tube Including a Tattoo Ink Reservoir for Manually Dispensing Tattoo Ink During TattooingAugust 2022October 2025Abandon3920NoNo
17849323CATHETER TIP EXPANDABLE IN COMPRESSIONJune 2022November 2025Allow4131YesNo
17827687Knotless Orthopedic Stabilization System and Related MethodsMay 2022May 2025Allow3611YesNo
17752399CAUSING ISCHEMIA IN TUMORSMay 2022March 2025Abandon3410NoNo
17664598TISSUE RETRACTION DEVICES AND RELATED METHODS OF USEMay 2022March 2025Allow3420YesNo
17748940METHOD FOR SHEARING TISSUEMay 2022August 2024Allow2710NoNo
17727750Prepuce Extruding, Cutting, Hemostasis, and Healing Assembly Using Ultrasonic WaveApril 2022August 2024Allow2830YesNo
17727752Prepuce Extruding, Cutting, Hemostasis, and Healing Assembly Using Ultrasonic WaveApril 2022October 2024Allow3030YesNo
17702920DONOR CORNEAL CUTTING BLADEMarch 2022November 2023Abandon1910NoNo
17699787Uterine ManipulatorMarch 2022August 2024Allow2930YesNo
17688767SECONDARY DEVICE HOLDER AND COMPRESSION SYSTEM, METHOD OF MAKING AND USING THE SAMEMarch 2022January 2026Allow4720NoNo
17670562TISSUE CONTAINMENT DEVICE FOR USE IN SURGICAL PROCEDURESFebruary 2022May 2025Allow3931YesNo
17635256SURGICAL ROBOT AND SURGICAL INSTRUMENTFebruary 2022March 2025Allow3710YesNo
17632298DEVICE FOR RECIPROCALLY PUNCTURING SKINFebruary 2022September 2025Allow4320YesNo
17578963VARIABLE LENGTH VASCULAR OCCLUSION SYSTEMJanuary 2022August 2025Abandon4330NoYes
17573627Tattoo ToolJanuary 2022August 2024Allow3110YesNo
17551248TILT-CONTROLLED GRIDDecember 2021January 2024Abandon2510NoNo
17548722Hair Grasping DeviceDecember 2021December 2023Abandon2510NoNo
17546685REAL-TIME SAMPLING SYSTEMDecember 2021February 2026Allow5130NoNo
17617356DEVICE FOR SUTURE TENSIONING AND METHODS THEREOFDecember 2021November 2024Allow3610YesNo
17543571VIBRATING SURGICAL INSTRUMENTDecember 2021February 2023Allow1440YesNo
17537325LESION CROSSING SHOCK WAVE CATHETERNovember 2021November 2024Allow3610YesNo
17527538NEEDLE AND CANNULA ASSEMBLY FOR CANNULATION AND TREATMENT OF SUBCUTANEOUS VESSELSNovember 2021July 2025Abandon4421NoNo
17518658TIME DEPENDENT PHYSIOLOGIC TISSUE SCAFFOLDNovember 2021December 2024Allow3830YesNo
17518496Delivery System for Articular Surface ImplantNovember 2021February 2024Allow2710YesNo
17512741LACRIMAL PLUG INSERTEROctober 2021February 2025Abandon4010NoNo
17452562PROTECTIVE DEVICE FOR USE DURING SURGERYOctober 2021August 2023Allow2250YesNo
17487890TROCARSeptember 2021December 2023Allow2650YesNo
17442286BALLOON CATHETERSeptember 2021February 2025Allow4110YesNo
17479589JAW DRIVE ARM FOR SURGICAL INSTRUMENTS AND SURGICAL INSTRUMENTS INCORPORATING THE SAMESeptember 2021March 2025Allow4240YesNo
17471046METHOD AND APPARATUS FOR CLOSING A FISSURE IN THE ANNULUS OF AN INTERVERTEBRAL DISC, AND/OR FOR EFFECTING OTHER ANATOMICAL REPAIRS AND/OR FIXATIONSSeptember 2021December 2024Abandon3910NoNo
17405252TROCAR STABILIZATION CLAMPAugust 2021February 2024Abandon3010YesNo
17384249Corneal Linear Axis MarkerJuly 2021October 2023Allow2720YesNo
17367874ENDOSCOPIC SUTURING SYSTEM HAVING EXTERNAL INSTRUMENT CHANNELJuly 2021June 2025Allow4730YesNo
17350101BALLOON CATHETER WITH HIGH ARTICULATIONJune 2021September 2023Allow2711NoNo
17346711PROSTHETIC HEART VALVEJune 2021November 2022Allow1740YesNo
17346127PROSTHETIC HEART VALVEJune 2021July 2022Abandon1310NoNo
17334835TATTOO NEEDLE UNITMay 2021September 2024Allow3930YesNo
17319136Prosthetic Heart Valves And Apparatus And Methods For Delivery Of SameMay 2021May 2023Allow2400YesNo
17291880DUAL CHECK VALVE ONE HANDED APPLICATORMay 2021March 2025Allow4621YesNo
17227201DEVICE AND METHOD FOR TREATING VASCULAR INSUFFICIENCYApril 2021November 2024Allow4340NoNo
17283198Variable Frequency Waveform Tattoo Needle MechanismApril 2021April 2024Allow3620YesNo
17213524CLIP APPLIER WITH STABILIZING MEMBERMarch 2021December 2024Allow4521NoNo
17213508AIRFLOW CHANNELS AND PATTERNS IN LUMEN FOR CANNULAMarch 2021February 2024Allow3520YesNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner BYRD, BRIGID K.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
4
Examiner Affirmed
2
(50.0%)
Examiner Reversed
2
(50.0%)
Reversal Percentile
79.0%
Higher than average

What This Means

With a 50.0% reversal rate, the PTAB reverses the examiner's rejections in a meaningful percentage of cases. This reversal rate is in the top 25% across the USPTO, indicating that appeals are more successful here than in most other areas.

Strategic Value of Filing an Appeal

Total Appeal Filings
10
Allowed After Appeal Filing
4
(40.0%)
Not Allowed After Appeal Filing
6
(60.0%)
Filing Benefit Percentile
67.4%
Higher than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 40.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is above the USPTO average, suggesting that filing an appeal can be an effective strategy for prompting reconsideration.

Strategic Recommendations

Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.

Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.

Examiner BYRD, BRIGID K - Prosecution Strategy Guide

Executive Summary

Examiner BYRD, BRIGID K works in Art Unit 3771 and has examined 250 patent applications in our dataset. With an allowance rate of 72.4%, this examiner has a below-average tendency to allow applications. Applications typically reach final disposition in approximately 32 months.

Allowance Patterns

Examiner BYRD, BRIGID K's allowance rate of 72.4% places them in the 36% percentile among all USPTO examiners. This examiner has a below-average tendency to allow applications.

Office Action Patterns

On average, applications examined by BYRD, BRIGID K receive 2.02 office actions before reaching final disposition. This places the examiner in the 52% percentile for office actions issued. This examiner issues a slightly above-average number of office actions.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by BYRD, BRIGID K is 32 months. This places the examiner in the 53% percentile for prosecution speed. Prosecution timelines are slightly faster than average with this examiner.

Interview Effectiveness

Conducting an examiner interview provides a +47.6% benefit to allowance rate for applications examined by BYRD, BRIGID K. This interview benefit is in the 92% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 30.0% of applications are subsequently allowed. This success rate is in the 58% percentile among all examiners. Strategic Insight: RCEs show above-average effectiveness with this examiner. Consider whether your amendments or new arguments are strong enough to warrant an RCE versus filing a continuation.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 31.7% of cases where such amendments are filed. This entry rate is in the 46% percentile among all examiners. Strategic Recommendation: This examiner shows below-average receptiveness to after-final amendments. You may need to file an RCE or appeal rather than relying on after-final amendment entry.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 120.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 83% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences are highly effective with this examiner compared to others. Before filing a full appeal brief, strongly consider requesting a PAC. The PAC provides an opportunity for the examiner and supervisory personnel to reconsider the rejection before the case proceeds to the PTAB.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 60.0% of appeals filed. This is in the 37% percentile among all examiners. Of these withdrawals, 50.0% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows below-average willingness to reconsider rejections during appeals. Be prepared to fully prosecute appeals if filed.

Petition Practice

When applicants file petitions regarding this examiner's actions, 28.6% are granted (fully or in part). This grant rate is in the 16% percentile among all examiners. Strategic Note: Petitions are rarely granted regarding this examiner's actions compared to other examiners. Ensure you have a strong procedural basis before filing a petition, as the Technology Center Director typically upholds this examiner's decisions.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 45% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 1.1% of allowed cases (in the 62% percentile). This examiner issues Quayle actions more often than average when claims are allowable but formal matters remain (MPEP § 714.14).

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Prioritize examiner interviews: Interviews are highly effective with this examiner. Request an interview after the first office action to clarify issues and potentially expedite allowance.
  • Request pre-appeal conferences: PACs are highly effective with this examiner. Before filing a full appeal brief, request a PAC to potentially resolve issues without full PTAB review.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.